Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASIA Study: French Register of Inflammatory Eye Disease Secondary to Cancer Immunotherapy

NCT04760197 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04760197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04760197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASIA Study: French Register of Inflammatory Eye Disease Secondary to Cancer Immunotherapy
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2019
Completion date
December 1, 2021
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

patients treated for cancer by immunotherapy